CD20, Human (Ublituximab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.

Search, find, compare suppliers for anti-CD20, Human (Ublituximab biosimilar) antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityCD20, Human (Ublituximab biosimilar)
CloneUblituximab
Host SpeciesRecombinant
Reactive Specieshuman
IsotypeIgG1 kappa
Formatpurified
Size1mg, 5mg
Concentration1mg/ml
Applicationsn/a
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionAnti-Human CD20 Recombinant Antibody (Ublituximab). Ublituximab is an immunomodulator. It binds to CD20. It is in Phase 3 clinical trials for multiple sclerosis. It is also in "U2" Phase 3 clinical trials for chronic lymphocytic leukemia in combination with Umbralisib.
Immunogenn/a
Other NamesAnti-CD20 Recombinant Antibody, Research Grade Ublituximab, Anti-Human CD20 Recombinant Antibody(Ublituximab), LFB-R603, TG-1101, TGTX-1101, Antibody Drug Analogues, Monoclonal Antibody, YR1251, Research Grade Biosimilars, Biosimilar Antibody
Gene, Accession #CAS: 1174014-05-1
Catalog #YR1251
Priceplease inquire
Order / More InfoCD20, Human (Ublituximab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.
Product Specific Referencesn/a
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
FL-4, Building A5
International Enterprise Community
Tianjin CHINA
P: 400-621-6806

info@kmdbioscience.com
Sales: sales@kmdbiosci.com

https://www.kmdbioscience.com

Profile of KMD BIOSCIENCE CO. LTD.

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.